Retatrutide RT50 50mg*10vials

Retatrutide RT50 (50mg x 10 vials) is the flagship product in the entire Retatrutide triad receptor agonist series, representing the highest-specification and most potent GLP-1/GIP/GCGR metabolic research peptide. RT50 is developed based on all previous RT series iterations (RT10/RT15/RT20/RT30/RT40), employing full-spectrum saturated molecular optimization and maximum-density active ingredient configuration to achieve unparalleled target binding efficiency, extremely strong metabolic regulatory intensity, and industry-leading experimental stability. As the highest-dose and most potent research-grade retatrutide currently available, it is specifically tailored for ultra-limited metabolic mechanism research, ultra-high-dose gradient efficacy validation, large-scale long-term preclinical projects, and high-standard extreme phenotypic modeling, making it a top-tier core raw material for professional pharmaceutical laboratories and cutting-edge metabolic research institutions.

Product Function and Research Value

Retatrutide RT50 exerts a full-saturation effect of synergistic metabolic regulation across three pathways, providing comprehensive, in-depth, and extreme intervention in complex systemic metabolic disorders. Its fully activated GLP-1 and GIP dual pathways achieve ultimate optimization of insulin sensitivity, thoroughly improve refractory severe insulin resistance, maintain long-term stable glycemic homeostasis, and produce super-strong and long-lasting appetite suppression and satiety, providing excellent and reliable experimental support for in-depth exploration of the pathogenesis of advanced diabetes and complex glucose metabolism disorders. The fully enhanced GCGR pathway maximizes resting energy expenditure, achieves deep oxidative decomposition of deep visceral fat and refractory adipose tissue, significantly improves refractory severe dyslipidemia, and promotes complete browning remodeling of white adipose tissue. RT50 is suitable for the most challenging cutting-edge research directions, including refractory extreme obesity, multidimensional metabolic remodeling throughout the entire life cycle, deep repair of metabolic organ damage, and ultra-high dose-effect boundary validation. It can produce highly significant experimental phenotypes, ultra-high precision data, and excellent reproducibility, providing comprehensive support for high-end preclinical research and the production of top academic results.

Core Product Advantages

1. RT50 Fully Saturated Ultimate Potency: The final iteration of the Retatrutide series, with a saturated optimized molecular structure, maximizing target binding activity. Its overall metabolic regulatory efficacy completely surpasses all lower-generation RT products, providing the most significant experimental differential phenotypes for high-standard scientific research. 2. 50mg full-strength ultra-high concentration: The top-of-the-line commercial flagship specification in the Retatrutide product line, with concentrations 5 times that of the traditional 10mg, 2.5 times that of 20mg, 1.67 times that of 30mg, and 1.25 times that of 40mg. Perfectly matched for ultra-long-term large animal models, extremely high-dose gradient control experiments, and large-scale multi-group parallel replicate experiments, avoiding data deviations caused by frequent dilution and solution changes. 3. Top-tier resistance to degradation and overall stability: Utilizing the latest fully stable molecular modification technology, it possesses strong resistance to in vitro and in vivo metabolic decay. Maintaining 100% saturated biological activity throughout the entire long experimental period, providing ultra-stable, highly consistent, and reproducible experimental data. 4. Pharmaceutical-grade ultra-high purity: Employing a sterile vacuum freeze-drying process to fully retain the activity of peptide molecules. Each batch of products undergoes rigorous HPLC purity testing and comes with a complete Certificate of Account (COA), boasting ultra-low impurity content, zero contamination risk, and top-tier pharmaceutical research-grade quality. 5. Standardized high-end bulk packaging: 10 vials per box, integrated aseptic packaging, ideal for long-term strategic reserves in laboratories, top-tier preclinical research by pharmaceutical companies, key national research projects, and large-scale global wholesale procurement.

Retatropeptide (RT50) 50mg*10 vials is the flagship product in the entire Retatropeptide series, representing the industry's top-tier formulation of peptides for GLP-1/GIP/GCGR three-target metabolic research. This product has undergone full-generation iterations from RT10 to RT40, employing global saturation molecular optimization technology and a high-density activity ratio. Its target binding saturation, metabolic regulation limits, and...